- Home
- CBUS vs INCR Comparison
CBUS vs INCR Comparison
Compare CBUS & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- INCR
- Stock Information
- Founded
- CBUS 2010
- INCR 1994
- Country
- CBUS United States
- INCR Israel
- Employees
- CBUS N/A
- INCR N/A
- Industry
- CBUS Agricultural Chemicals
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- INCR Health Care
- Exchange
- CBUS Nasdaq
- INCR Nasdaq
- Market Cap
- CBUS 65.3M
- INCR 76.7M
- IPO Year
- CBUS 2017
- INCR N/A
- Fundamental
- Price
- CBUS $3.34
- INCR $1.57
- Analyst Decision
- CBUS Strong Buy
- INCR
- Analyst Count
- CBUS 3
- INCR 0
- Target Price
- CBUS $22.00
- INCR N/A
- AVG Volume (30 Days)
- CBUS 155.8K
- INCR 8.6K
- Earning Date
- CBUS 05-08-2025
- INCR 05-01-2025
- Dividend Yield
- CBUS N/A
- INCR N/A
- EPS Growth
- CBUS N/A
- INCR N/A
- EPS
- CBUS N/A
- INCR N/A
- Revenue
- CBUS $4,751,000.00
- INCR $65,575,323.00
- Revenue This Year
- CBUS $32.97
- INCR $69.54
- Revenue Next Year
- CBUS $66.40
- INCR $41.75
- P/E Ratio
- CBUS N/A
- INCR N/A
- Revenue Growth
- CBUS 104.78
- INCR N/A
- 52 Week Low
- CBUS $1.40
- INCR $1.17
- 52 Week High
- CBUS $15.06
- INCR $3.28
- Technical
- Relative Strength Index (RSI)
- CBUS 63.81
- INCR 55.03
- Support Level
- CBUS $2.16
- INCR $1.51
- Resistance Level
- CBUS $3.40
- INCR $1.59
- Average True Range (ATR)
- CBUS 0.33
- INCR 0.05
- MACD
- CBUS 0.06
- INCR -0.00
- Stochastic Oscillator
- CBUS 85.60
- INCR 55.63
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.